We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMTC icon
51
Semtech
SMTC
$12.2B
$493K 0.57%
9,445
+965
+11% +$45.2K
FE icon
52
FirstEnergy
FE
$27.1B
$491K 0.56%
+12,657
New +$523K
BEN icon
53
Franklin Resources
BEN
$17B
$489K 0.56%
+23,311
New +$440K
CCEP icon
54
Coca-Cola Europacific Partners
CCEP
$46.9B
$484K 0.56%
12,819
+4,368
+52% +$171K
PHM icon
55
Pultegroup
PHM
$24.8B
$483K 0.55%
14,194
+7,610
+116% +$228K
WAT icon
56
Waters Corp
WAT
$40.4B
$481K 0.55%
+2,667
New +$504K
BSX icon
57
Boston Scientific
BSX
$73.1B
$475K 0.54%
13,541
+8,081
+148% +$291K
JBL icon
58
Jabil
JBL
$35.3B
$473K 0.54%
+14,755
New +$425K
ICE icon
59
Intercontinental Exchange
ICE
$84.5B
$456K 0.52%
+4,979
New +$456K
DCI icon
60
Donaldson
DCI
$11.2B
$454K 0.52%
9,758
+8,523
+690% +$377K
CRUS icon
61
Cirrus Logic
CRUS
$6.11B
$452K 0.52%
7,324
+6,544
+839% +$447K
JNPR
62
DELISTED
Juniper Networks
JNPR
$447K 0.51%
19,532
+12,526
+179% +$288K
SIRI icon
63
SiriusXM
SIRI
$9.7B
$445K 0.51%
7,574
+865
+13% +$48.5K
OZK icon
64
Bank OZK
OZK
$5.63B
$444K 0.51%
18,920
-6,699
-26% -$144K
BRKR icon
65
Bruker
BRKR
$8.58B
$438K 0.5%
+10,774
New +$424K
ALLE icon
66
Allegion
ALLE
$14.1B
$436K 0.5%
4,265
-1,764
-29% -$174K
NI icon
67
NiSource
NI
$20B
$436K 0.5%
19,191
+17,096
+816% +$412K
CMC icon
68
Commercial Metals
CMC
$8.1B
$435K 0.5%
+21,344
New +$366K
META icon
69
Meta Platforms (Facebook)
META
$1.52T
$432K 0.5%
+1,903
New +$397K
XLRN
70
DELISTED
Acceleron Pharma
XLRN
$432K 0.5%
+4,535
New +$437K
J icon
71
Jacobs Solutions
J
$17.2B
$427K 0.49%
+6,085
New +$410K
MRVL icon
72
Marvell Technology
MRVL
$187B
$422K 0.48%
12,046
+1,899
+19% +$55.6K
DOV icon
73
Dover
DOV
$28.3B
$417K 0.48%
4,321
+3,735
+637% +$345K
MRSH
74
Marsh
MRSH
$91B
$410K 0.47%
3,817
+2,214
+138% +$224K
STE icon
75
Steris
STE
$23.3B
$402K 0.46%
+2,618
New +$399K

Similar funds

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.